Clinical Report: Impact of Organized Nursing Strategies on Morbidity in HSCT

Overview

A structured nursing intervention program significantly reduced complication-related morbidity in leukemia patients undergoing hematopoietic stem cell transplantation (HSCT). Key outcomes included decreased rates of febrile neutropenia, oral mucositis, and infections, alongside shorter hospital stays.

Background

Hematopoietic stem cell transplantation (HSCT) is a critical treatment for leukemia but is associated with high morbidity due to complications such as infections and graft-vs.-host disease (GVHD). Effective nursing strategies are essential to mitigate these risks and improve patient outcomes. This study evaluates the impact of organized nursing interventions on reducing complications in this vulnerable patient population.

Data Highlights

Key Findings

• Significant reduction in febrile neutropenia from 64.2% to 37.7% (p = 0.002).
• Decrease in oral mucositis Grade ≥2 from 54.7% to 28.3% (p = 0.001).
• Reduction in documented infections from 49.1% to 26.4% (p = 0.004).
• Acute GVHD rates decreased from 41.9% to 24.2% (p = 0.031).
• Hospital length of stay decreased from 28.6 to 23.2 days (p = 0.001).
• 30-day readmission rates fell from 18.9% to 8.5% (p = 0.038).

Clinical Implications

The implementation of structured nursing interventions can lead to significant improvements in clinical outcomes for leukemia patients undergoing HSCT. These findings suggest that routine integration of evidence-based nursing protocols may enhance patient care and reduce complication-related morbidity.

Conclusion

The study demonstrates that organized nursing strategies effectively reduce morbidity and improve outcomes in leukemia patients receiving HSCT. These results support the adoption of standardized nursing protocols in clinical practice.

Related Resources & Content

1. ASTCT Committee on Practice Guidelines, Transplantation and Cellular Therapy, 2026 -- Clinical Management of Acute Graft-Versus-Host Disease: An Evidence-Based Review
2. CDC, 2025 -- CLABSI Basics | Central Line-associated Bloodstream Infections
3. npj Digital Medicine — Forecasting Complications for Risk Assessment of Chemotherapy-Induced Stem Cell Mobilization in Multiple Myeloma
4. The ASCO Post — Reduced-Intensity Related-Donor Haploidentical vs HLA-Matched Sibling-Donor Hematopoietic Cell Transplantation in Lymphoma
5. Bone Marrow Transplantation — Phase II Trial Evaluating Chimerism-Driven Immunosuppression Reduction Following Non-Myeloablative Conditioning—Eudract #: 2007-002420-15
6. Bone Marrow Transplantation — Effects of Bone Marrow Fibrosis on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in Patients with Acute Myeloid Leukemia
7. Forecasting Complications for Risk Assessment of Chemotherapy-Induced Stem Cell Mobilization in Multiple Myeloma
8. Reduced-Intensity Related-Donor Haploidentical vs HLA-Matched Sibling-Donor Hematopoietic Cell Transplantation in Lymphoma
9. Clinical Management of Acute Graft-Versus-Host Disease: An Evidence-Based Review from the ASTCT Committee on Practice Guidelines - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy
10. CLABSI Basics | Central Line-associated Bloodstream Infections | CDC | CLABSI
11. Is photobiomodulation an effective preventive strategy for oral mucositis in patients with hematologic diseases undergoing chemotherapy?: A systematic review of randomized controlled trials | Lasers in Medical Science | Springer Nature Link